We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-1.54%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$83.7B
AUM Growth
-$1.57B
Cap. Flow
-$3.66B
Cap. Flow %
-4.37%
Top 10 Hldgs %
8.74%
Holding
5,820
New
545
Increased
1,802
Reduced
1,597
Closed
678

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$365M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$307M
3
ADBE icon
Adobe
ADBE
+$250M
4
NVDA icon
NVIDIA
NVDA
+$242M
5
CRM icon
Salesforce
CRM
+$240M

Sector Composition

Rank Sector Weight
1 Technology 13.15%
2 Financials 9.51%
3 Healthcare 7.52%
4 Consumer Discretionary 6.79%
5 Communication Services 5.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMSF icon
5001
AMERISAFE
AMSF
$490M
-4,915
Closed -$256K
AMTB icon
5002
Amerant Bancorp
AMTB
$1.13B
-22,274
Closed -$626K
ANGO icon
5003
AngioDynamics
ANGO
$652M
-23,327
Closed -$451K
APLT
5004
DELISTED
Applied Therapeutics
APLT
-71,098
Closed -$67K
APP icon
5005
CALL
Applovin
APP
$99.9B
-10,000
Closed -$344K
APP icon
5006
Applovin
APP
$99.9B
-158,271
Closed -$5.45M
APP icon
5007
PUT
Applovin
APP
$99.9B
-43,100
Closed -$1.48M
APRE icon
5008
Aprea Therapeutics
APRE
$10.1M
-2,488
Closed -$37K
APTV icon
5009
CALL
Aptiv
APTV
$9.83B
-9,300
Closed -$828K
APYX icon
5010
Apyx Medical
APYX
$130M
-24,586
Closed -$144K
AQN icon
5011
Algonquin Power & Utilities
AQN
$4.38B
-114,658
Closed -$1.54M
AQST icon
5012
Aquestive Therapeutics
AQST
$602M
-164,607
Closed -$106K
ARDX icon
5013
Ardelyx
ARDX
$966M
-522,668
Closed -$308K
ARE icon
5014
Alexandria Real Estate Equities
ARE
$9.3B
-106,327
Closed -$15.4M
ARWR icon
5015
Arrowhead Research
ARWR
$12.3B
-8,189
Closed -$288K
ASLE icon
5016
AerSale
ASLE
$268M
-12,677
Closed -$184K
ASTE icon
5017
Astec Industries
ASTE
$1B
-5,783
Closed -$236K
OPTU
5018
CALL
Optimum Communications Inc
OPTU
$328M
-15,600
Closed -$144K
AU icon
5019
PUT
AngloGold Ashanti
AU
$60.9B
-12,500
Closed -$185K
AVB
5020
CALL
DELISTED
AvalonBay Communities
AVB
-49,200
Closed -$9.56M
AVPT icon
5021
AvePoint
AVPT
$2.8B
-49,200
Closed -$213K
AVT icon
5022
Avnet
AVT
$7.08B
-177,649
Closed -$7.62M
AVTX icon
5023
Avalo Therapeutics
AVTX
$1.03B
-72
Closed -$104K
AXSM icon
5024
Axsome Therapeutics
AXSM
$10.8B
-6,762
Closed -$259K
AYTU icon
5025
AYTU BioPharma
AYTU
$24.8M
-912
Closed -$13K

Similar funds

David Shaw's Q3 2022 Portfolio in Review

As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

David Shaw withdrew a net $3.66B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, David Shaw opened a new position in Prologis worth $66.1M.

  • David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
  • David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
  • David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
  • David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
  • David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
  • David Shaw opened 545 new positions and closed 678 in Q3 2022.
  • David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.